Form 8-K - Current report:
SEC Accession No. 0001140361-25-040539
Filing Date
2025-11-05
Accepted
2025-11-05 16:11:33
Documents
14
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20058354_8k.htm   iXBRL 8-K 29810
2 EXHIBIT 99.1 ef20058354_ex99-1.htm EX-99.1 344624
6 image00002.jpg GRAPHIC 3577
  Complete submission text file 0001140361-25-040539.txt   532555

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20251105.xsd EX-101.SCH 3881
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20251105_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20251105_pre.xml EX-101.PRE 16055
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20058354_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 251454083
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)